上海中医药大学基础医学院
纸质出版:2019
移动端阅览
[1]张倩霞,陈少丽,文小平,都广礼.五苓散要药“桂枝”在五苓散对阿霉素肾病大鼠肾脏保护中的作用[J].中医杂志,2019,60(02):150-154.
ZHANG Qianxia, CHEN Shaoli, WEN Xiaoping, et al. Effects of Ramulus Cinnamomi in Kidney-Protecting Effect of Wuling Powder(五苓散) on Adriamycin Nephropathy Model Rats[J]. Journal of Traditional Chinese Medicine2019, 60(2): 150-154.
[1]张倩霞,陈少丽,文小平,都广礼.五苓散要药“桂枝”在五苓散对阿霉素肾病大鼠肾脏保护中的作用[J].中医杂志,2019,60(02):150-154. DOI: 10.13288/j.11-2166/r.2019.02.014.
ZHANG Qianxia, CHEN Shaoli, WEN Xiaoping, et al. Effects of Ramulus Cinnamomi in Kidney-Protecting Effect of Wuling Powder(五苓散) on Adriamycin Nephropathy Model Rats[J]. Journal of Traditional Chinese Medicine2019, 60(2): 150-154. DOI: 10.13288/j.11-2166/r.2019.02.014.
目的探讨五苓散"要药"桂枝在五苓散对阿霉素肾病大鼠肾损伤保护中的作用及可能机制。方法尾静脉注射盐酸阿霉素(3 mg/kg)两次复制SD大鼠肾损伤模型
造模成功的60只大鼠随机分为模型组、贝那普利组、五苓散组、五苓散去桂枝组、五苓散去桂枝加桂皮醛组
每组12只;另选取健康SD大鼠12只设为正常组。贝那普利组给予浓度为1. 2 mg/ml的盐酸贝那普利片溶液灌胃
五苓散组给予浓度为1. 6 mg/ml五苓散溶液灌胃
五苓散去桂枝组给予浓度为1. 4 mg/ml五苓散去桂枝溶液灌胃
五苓散去桂枝加桂皮醛组给予浓度为1. 403 mg/ml五苓散去桂枝加桂皮醛溶液(其中桂皮醛的终浓度为3 mg/ml)灌胃。各组按照10 ml/kg剂量灌胃
正常组和模型组灌胃等体积生理盐水
每日1次
共28天。末次给药后记录大鼠24 h尿量
检测大鼠尿蛋白含量
血浆肌酐、尿素氮、总胆固醇、甘油三酯水平
以及血浆丙二醛(MDA)、谷胱甘肽(GSH)含量及超氧化物歧化酶(SOD)活力;大鼠肾脏组织HE染色进行病理学观察。结果与正常组比较
模型组大鼠24 h尿量降低
尿蛋白含量及血浆肌酐、甘油三酯、总胆固醇、MDA、GSH含量升高
SOD活性降低(P <0. 05或P <0. 01)
病理可见肾小球硬化
肾小管上皮细胞变性肿胀
间质纤维组织增生。与模型组比较
五苓散组、五苓散去桂枝组、五苓散去桂枝加桂皮醛组均可降低大鼠24 h尿蛋白含量
升高血浆SOD活力(P <0. 05或P <0. 01)
改善肾脏病理变化;且五苓散去桂枝加桂皮醛组亦降低血浆肌酐、MDA、GSH含量
提高24 h尿量(P <0. 05或P <0. 01)
肾脏病理改善更明显。结论桂皮醛可能是五苓散"要药"桂枝的主要活性成分
其抗阿霉素肾病大鼠肾损伤的机制可能与抗氧化应激有关。
Objective To investigate the effects and possible mechanism of the main component Ramulus Cinnamomi in the protective effect of Wuling Powder(五苓散) on renal injury in rats with adriamycin-induced nephropathy.Methods Doxorubicin hydrochloride(3 mg/kg) was injected twice into the tail vein to replicate the renal injury model of Sprague Dawley(SD) rats. A total of 60 successful modeling rats were randomly divided into model group
benazepril group
Wuling Powder group
Wuling Powder without Ramulus Cinnamomi group
and Wuling Powder without Ramulus Cinnamomi plus cinnamaldehyde group
with 12 in each group. Another 12 healthy SD rats were also selected as normal group. The benazepril group was given intragastric administration of benazepril hydrochloride tablet solution at a concentration of 1. 2 mg/ml. The Wuling Powder group was given intragastric administration of Wuling Powder solution at a concentration of 1. 6 mg/ml. The Wuling Powder group without Ramulus Cinnamomi was given intragastric administration of the Wuling Powder without Ramulus Cinnamomi solution at a concentration of 1. 4 mg/ml.The Wuling Powder without Ramulus Cinnamomiwas plus cinnamaldehyde given group was given intragastric administration of Wuling Powder without Ramulus Cinnamomiwas plus cinnamaldehyde given solution at a concentration of1. 403 mg/ml(final concentration of cinnamaldehyde was 3 mg/ml). Each group was intragastrically administered at a dose of 10 ml/kg
and the normal and model groups were intragastrically administered with an equal volume of normal saline once a day for 28 days. After the last administration
the 24-hour urine volume of rats was recorded
and the urinary protein content
plasma creatinine
urea nitrogen
total cholesterol
triglyceride levels
and plasma malondialdehyde(MDA)
glutathione(GSH) content
and superoxide dismutase(SOD) activity were measured. HE(hematoxylin-eosin) staining of rat kidney tissue was performed for pathological observation. Results Compared with the normal group
the rats in the model group had decreased 24-hour urine volume
increased urinary protein content and plasma creatinine
triglyceride
total cholesterol
MDA
GSH content
and decreased SOD activity(P < 0. 05 or P <0. 01). Glomerulosclerosis
degeneration and swelling of renal tubular epithelial cells
and interstitial fibrous tissue proliferation were observed pathologically. Compared with the model group
Wuling Powder group
Wuling Powder without Ramulus Cinnamomi group
and Wuling Powder without Ramulus Cinnamomi plus cinnamaldehyde group reduced the 24-hour urinary protein content
increased plasma SOD activity(P < 0. 05 or P < 0. 01)
and improved changes of renal pathology. Wuling Powder without Ramulus Cinnamomi plus cinnamaldehyde group also decreased plasma creatinine
MDA
GSH content
and increase 24-hour urine volume(P < 0. 05 or P < 0. 01). The kidney pathological improvement was more obvious. Conclusion Cinnamaldehyde may be the main active component of Ramulus Cinnamomi
the key drug of Wuling Powder
and its mechanism on renal injury in rats with adriamycininduced nephropathy may be related to anti-oxidative stress.
0
浏览量
350
下载量
8
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号